Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 309

1.

CAL2 monoclonal antibody is a rapid and sensitive assay for the detection of calreticulin mutations in essential thrombocythemia patients.

Bonifacio M, Montemezzi R, Parisi A, De Matteis G, Bertorelle R, Scaffidi L, Candiotto C, Lippi G, Zamò A, Chilosi M, Pizzolo G, Scarpa A, Krampera M.

Ann Hematol. 2019 Jun 27. doi: 10.1007/s00277-019-03741-8. [Epub ahead of print]

PMID:
31250082
2.

Safety and efficacy of switching from branded to generic imatinib in chronic phase chronic myeloid leukemia patients treated in Italy.

Bonifacio M, Scaffidi L, Binotto G, Miggiano MC, Danini M, Minotto C, Griguolo D, Marin L, Frison L, D'Amore F, Basso M, Sartori R, Tinelli M, Stulle M, Fortuna S, Bonalumi A, Bertoldero G, De Biasi E, Ruggeri M, Semenzato G, Fanin R, Pizzolo G, Krampera M, Tiribelli M.

Leuk Res. 2018 Nov;74:75-79. doi: 10.1016/j.leukres.2018.09.018. Epub 2018 Oct 2.

PMID:
30308414
3.

Excellent outcomes of 2G-TKI therapy after imatinib failure in chronic phase CML patients.

Tiribelli M, Bonifacio M, Binotto G, Iurlo A, Cibien F, Maino E, Guella A, Festini G, Minotto C, De Biasi E, De Marchi F, Scaffidi L, Frison L, Bucelli C, Medeot M, Calistri E, Sancetta R, Stulle M, Orofino N, Krampera M, Gherlinzoni F, Semenzato G, Pizzolo G, Ambrosetti A, Fanin R.

Oncotarget. 2018 Feb 12;9(18):14219-14227. doi: 10.18632/oncotarget.24478. eCollection 2018 Mar 6.

4.

Low catalase expression confers redox hypersensitivity and identifies an indolent clinical behavior in CLL.

Cavallini C, Chignola R, Dando I, Perbellini O, Mimiola E, Lovato O, Laudanna C, Pizzolo G, Donadelli M, Scupoli MT.

Blood. 2018 Apr 26;131(17):1942-1954. doi: 10.1182/blood-2017-08-800466. Epub 2018 Feb 21.

5.

Integration of B-cell receptor-induced ERK1/2 phosphorylation and mutations of SF3B1 gene refines prognosis in treatment-naïve chronic lymphocytic leukemia.

Cavallini C, Visco C, Putta S, Rossi D, Mimiola E, Purvis N, Lovato O, Perbellini O, Falisi E, Facco M, Trentin L, Romanelli MG, Semenzato G, Ambrosetti A, Gaidano G, Pizzolo G, Cesano A, Scupoli MT.

Haematologica. 2017 Apr;102(4):e144-e147. doi: 10.3324/haematol.2016.154450. Epub 2016 Dec 7. No abstract available.

6.

Bortezomib, Thalidomide and Lenalidomide: Have They Really Changed the Outcome of Multiple Myeloma?

Mian M, Tinelli M, DE March E, Turri G, Meneghini V, Pescosta N, Berno T, Marabese A, Mondello P, Patriarca F, Pizzolo G, Semenzato G, Cortelazzo S, Zambello R.

Anticancer Res. 2016 Mar;36(3):1059-65.

PMID:
26976998
7.

Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia.

Cavallini C, Lovato O, Bertolaso A, Zoratti E, Malpeli G, Mimiola E, Tinelli M, Aprili F, Tecchio C, Perbellini O, Scarpa A, Zamò A, Cassatella MA, Pizzolo G, Scupoli MT.

Oncotarget. 2015 Oct 13;6(31):32061-74. doi: 10.18632/oncotarget.5201.

8.

Cellular Senescence Markers p16INK4a and p21CIP1/WAF Are Predictors of Hodgkin Lymphoma Outcome.

Caliò A, Zamò A, Ponzoni M, Zanolin ME, Ferreri AJ, Pedron S, Montagna L, Parolini C, Fraifeld VE, Wolfson M, Yanai H, Pizzolo G, Doglioni C, Vinante F, Chilosi M.

Clin Cancer Res. 2015 Nov 15;21(22):5164-72. doi: 10.1158/1078-0432.CCR-15-0508. Epub 2015 Jul 21.

9.

Multicentre survey to explore current survival of patients with acute myeloid leukaemia who failed induction chemotherapy.

Lazzarotto D, Candoni A, Nadali G, Pavan L, Lessi F, Mosna F, Simeone E, Ventura G, Gherlinzoni F, Semenzato G, Pizzolo G, Fanin R.

Eur J Haematol. 2016 Jun;96(6):586-92. doi: 10.1111/ejh.12635. Epub 2015 Aug 17.

PMID:
26186084
10.

Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival.

Visco C, Falisi E, Young KH, Pascarella M, Perbellini O, Carli G, Novella E, Rossi D, Giaretta I, Cavallini C, Scupoli MT, De Rossi A, D'Amore ES, Rassu M, Gaidano G, Pizzolo G, Ambrosetti A, Rodeghiero F.

Oncotarget. 2015 Jul 30;6(21):18653-63.

11.

The association of rituximab and a thrombopoietin receptor agonist in high-risk refractory immune thrombocytopenic purpura.

Veneri D, Soligo L, Pizzolo G, Ambrosetti A.

Blood Transfus. 2015 Oct;13(4):694-5. doi: 10.2450/2015.0325-14. Epub 2015 Apr 21. No abstract available.

12.

Role of blood cells dynamism on hemostatic complications in low-risk patients with essential thrombocythemia.

Piccin A, Steurer M, Mitterer M, Blöchl EM, Marcheselli L, Pusceddu I, Marabese A, Bertozzi I, Corvetta D, Randi ML, Elli E, Pogliani EM, Veneri D, Perbellini O, Krampera M, Pacquola E, Gottardi M, Tiribelli M, Guella A, Innella B, Vivaldi P, De Biasi E, Sancetta R, Rocconi R, Bassan R, Gherlinzoni F, Pizzolo G, Gastl G, Cortelazzo S.

Intern Emerg Med. 2015 Jun;10(4):451-60. doi: 10.1007/s11739-015-1186-8. Epub 2015 Jan 14.

PMID:
25585678
13.

The impact of sensitive KIT D816V detection on recognition of indolent Systemic Mastocytosis.

De Matteis G, Zanotti R, Colarossi S, De Benedittis C, Garcia-Montero A, Bonifacio M, Sartori M, Aprili F, Caruso B, Paviati E, Carli G, Perbellini O, Zamò A, Bonadonna P, Pizzolo G, Guidi G, Martinelli G, Soverini S.

Leuk Res. 2015 Mar;39(3):273-8. doi: 10.1016/j.leukres.2014.11.029. Epub 2014 Dec 6.

PMID:
25582384
14.

The high oxygen affinity haemoglobin Nantes: a family case description.

Artuso A, Balter R, Bonetti E, Zambon C, Ravani A, Dolcini B, Masieri MT, Salvagno GL, Zanotti R, Pizzolo G, Veneri D.

Blood Transfus. 2015 Jul;13(3):524-7. doi: 10.2450/2014.0206-14. Epub 2014 Dec 10. No abstract available.

15.

Immunophenotypic analysis of hematopoiesis in patients suffering from Shwachman-Bodian-Diamond Syndrome.

Mercuri A, Cannata E, Perbellini O, Cugno C, Balter R, Zaccaron A, Tridello G, Pizzolo G, De Bortoli M, Krampera M, Cipolli M, Cesaro S.

Eur J Haematol. 2015 Oct;95(4):308-15. doi: 10.1111/ejh.12490. Epub 2015 Feb 10.

PMID:
25402872
16.

Up-regulation of CXCL8/interleukin-8 production in response to CXCL12 in chronic lymphocytic leukemia.

Perbellini O, Cioffi F, Malpeli G, Zanolin E, Lovato O, Scarpa A, Pizzolo G, Scupoli MT.

Leuk Lymphoma. 2015 Jun;56(6):1897-900. doi: 10.3109/10428194.2014.977889. Epub 2014 Nov 19. No abstract available.

PMID:
25347424
17.

Rapid reconstitution of functionally active 6-sulfoLacNAc(+) dendritic cells (slanDCs) of donor origin following allogeneic haematopoietic stem cell transplant.

Mimiola E, Marini O, Perbellini O, Micheletti A, Vermi W, Lonardi S, Costantini C, Meneghelli E, Andreini A, Bonetto C, Vassanelli A, Cantini M, Zoratti E, Massi D, Zamo' A, Leso A, Quaresmini G, Benedetti F, Pizzolo G, Cassatella MA, Tecchio C.

Clin Exp Immunol. 2014 Oct;178(1):129-41. doi: 10.1111/cei.12387.

18.

Clinical significance of LAIR1 (CD305) as assessed by flow cytometry in a prospective series of patients with chronic lymphocytic leukemia.

Perbellini O, Falisi E, Giaretta I, Boscaro E, Novella E, Facco M, Fortuna S, Finotto S, Amati E, Maniscalco F, Montaldi A, Alghisi A, Aprili F, Bonaldi L, Paolini R, Scupoli MT, Trentin L, Ambrosetti A, Semenzato G, Pizzolo G, Rodeghiero F, Visco C.

Haematologica. 2014 May;99(5):881-7. doi: 10.3324/haematol.2013.096362. Epub 2014 Jan 10.

19.

Anti-Müllerian hormone and antral follicle count reveal a late impairment of ovarian reserve in patients undergoing low-gonadotoxic regimens for hematological malignancies.

Di Paola R, Costantini C, Tecchio C, Salvagno GL, Montemezzi R, Perandini A, Pizzolo G, Zaffagnini S, Franchi M.

Oncologist. 2013;18(12):1307-14. doi: 10.1634/theoncologist.2013-0138. Epub 2013 Oct 22.

20.

EUTOS score predicts long-term outcome but not optimal response to imatinib in patients with chronic myeloid leukaemia.

Tiribelli M, Bonifacio M, Calistri E, Binotto G, Maino E, Marin L, Guardalben E, Branca A, Gherlinzoni F, Semenzato G, Sancetta R, Pizzolo G, Fanin R.

Leuk Res. 2013 Nov;37(11):1457-60. doi: 10.1016/j.leukres.2013.07.037. Epub 2013 Aug 11.

PMID:
23993428
21.

Bendamustine in chronic lymphocytic leukemia: outcome according to different clinical and biological prognostic factors in the everyday clinical practice.

Zaja F, Mian M, Volpetti S, Visco C, Sissa C, Nichele I, Castelli M, Ambrosetti A, Puglisi S, Fanin R, Cortelazzo S, Pizzolo G, Trentin L, Rodeghiero F, Paolini R, Vivaldi P, Sancetta R, Isola M, Semenzato G.

Am J Hematol. 2013 Nov;88(11):955-60. doi: 10.1002/ajh.23546. Epub 2013 Sep 9.

22.

Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts.

Chiaretti S, Vitale A, Cazzaniga G, Orlando SM, Silvestri D, Fazi P, Valsecchi MG, Elia L, Testi AM, Mancini F, Conter V, te Kronnie G, Ferrara F, Di Raimondo F, Tedeschi A, Fioritoni G, Fabbiano F, Meloni G, Specchia G, Pizzolo G, Mandelli F, Guarini A, Basso G, Biondi A, Foà R.

Haematologica. 2013 Nov;98(11):1702-10. doi: 10.3324/haematol.2012.080432. Epub 2013 May 28.

23.

Old and new prognostic factors in acute myeloid leukemia with deranged core-binding factor beta.

Cairoli R, Beghini A, Turrini M, Bertani G, Nadali G, Rodeghiero F, Castagnola C, Lazzaroni F, Nichelatti M, Ferrara F, Pizzolo G, Pogliani E, Rossi G, Martinelli G, Morra E.

Am J Hematol. 2013 Jul;88(7):594-600. doi: 10.1002/ajh.23461. Epub 2013 Jun 5.

24.

The TNF-family cytokine TL1A inhibits proliferation of human activated B cells.

Cavallini C, Lovato O, Bertolaso A, Pacelli L, Zoratti E, Zanolin E, Krampera M, Zamò A, Tecchio C, Cassatella MA, Pizzolo G, Scupoli MT.

PLoS One. 2013;8(4):e60136. doi: 10.1371/journal.pone.0060136. Epub 2013 Apr 2.

25.

Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia.

Visco C, Moretta F, Falisi E, Facco M, Maura F, Novella E, Nichele I, Finotto S, Giaretta I, Ave E, Perbellini O, Guercini N, Scupoli MT, Trentin L, Trimarco V, Neri A, Semenzato G, Rodeghiero F, Pizzolo G, Ambrosetti A.

Am J Hematol. 2013 Apr;88(4):277-82. doi: 10.1002/ajh.23396. Epub 2013 Feb 28.

26.

On the cytokines produced by human neutrophils in tumors.

Tecchio C, Scapini P, Pizzolo G, Cassatella MA.

Semin Cancer Biol. 2013 Jun;23(3):159-70. doi: 10.1016/j.semcancer.2013.02.004. Epub 2013 Feb 11. Review.

PMID:
23410636
27.

Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantation.

Visco C, Finotto S, Zambello R, Paolini R, Menin A, Zanotti R, Zaja F, Semenzato G, Pizzolo G, D'Amore ES, Rodeghiero F.

J Clin Oncol. 2013 Apr 10;31(11):1442-9. doi: 10.1200/JCO.2012.45.9842. Epub 2013 Feb 11.

PMID:
23401442
28.

VR09 cell line: an EBV-positive lymphoblastoid cell line with in vivo characteristics of diffuse large B cell lymphoma of activated B-cell type.

Nichele I, Zamò A, Bertolaso A, Bifari F, Tinelli M, Franchini M, Stradoni R, Aprili F, Pizzolo G, Krampera M.

PLoS One. 2012;7(12):e52811. doi: 10.1371/journal.pone.0052811. Epub 2012 Dec 21.

29.

Haemorrhage and amyloidosis.

Veneri D, Pizzolo G, Bonalumi A, Franchini M.

Br J Haematol. 2013 Mar;160(6):854. doi: 10.1111/bjh.12166. Epub 2012 Dec 13. No abstract available.

PMID:
23240783
30.

Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies.

Cesano A, Perbellini O, Evensen E, Chu CC, Cioffi F, Ptacek J, Damle RN, Chignola R, Cordeiro J, Yan XJ, Hawtin RE, Nichele I, Ware JR, Cavallini C, Lovato O, Zanotti R, Rai KR, Chiorazzi N, Pizzolo G, Scupoli MT.

Haematologica. 2013 Apr;98(4):626-34. doi: 10.3324/haematol.2012.071910. Epub 2012 Nov 9.

31.

Predictors of anxiety and depression in hematopoietic stem cell transplant patients during protective isolation.

Tecchio C, Bonetto C, Bertani M, Cristofalo D, Lasalvia A, Nichele I, Bonani A, Andreini A, Benedetti F, Ruggeri M, Pizzolo G.

Psychooncology. 2013 Aug;22(8):1790-7. doi: 10.1002/pon.3215. Epub 2012 Nov 7.

PMID:
23132747
32.

α-bisabolol is an effective proapoptotic agent against BCR-ABL(+) cells in synergism with Imatinib and Nilotinib.

Bonifacio M, Rigo A, Guardalben E, Bergamini C, Cavalieri E, Fato R, Pizzolo G, Suzuki H, Vinante F.

PLoS One. 2012;7(10):e46674. doi: 10.1371/journal.pone.0046674. Epub 2012 Oct 3.

33.

A novel large-sized BCR-ABL transcript in a case of chronic myeloid leukaemia characterised by a favourable clinical course.

De Matteis G, Veneri D, Aprili F, Benati M, Paviati E, Guidi GC, Pizzolo G, Tecchio C.

Ann Hematol. 2013 Mar;92(3):413-5. doi: 10.1007/s00277-012-1587-y. Epub 2012 Oct 7. No abstract available.

PMID:
23053185
34.

The National Institutes of Health criteria for classification and scoring of chronic graft versus host disease: long-term follow-up of a single center series.

Tecchio C, Mosna F, Andreini A, Paoli L, Di Bella R, de Sabata D, Sorio M, Pizzolo G, Benedetti F.

Leuk Lymphoma. 2013 May;54(5):1020-7. doi: 10.3109/10428194.2012.733877. Epub 2013 Feb 19.

PMID:
23035648
35.

Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy.

Nwabo Kamdje AH, Bassi G, Pacelli L, Malpeli G, Amati E, Nichele I, Pizzolo G, Krampera M.

Blood Cancer J. 2012 May;2(5):e73. doi: 10.1038/bcj.2012.17. Epub 2012 May 25.

36.

Signaling pathways activated by the B-cell receptor in chronic lymphocytic leukemia.

Scupoli MT, Pizzolo G.

Expert Rev Hematol. 2012 Jun;5(3):341-8. doi: 10.1586/ehm.12.21. Review.

PMID:
22780213
37.

Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: correlations with clinicobiologic parameters.

Rigolin GM, Cibien F, Martinelli S, Formigaro L, Rizzotto L, Tammiso E, Saccenti E, Bardi A, Cavazzini F, Ciccone M, Nichele I, Pizzolo G, Zaja F, Fanin R, Galieni P, Dalsass A, Mestichelli F, Testa N, Negrini M, Cuneo A.

Blood. 2012 Mar 8;119(10):2310-3. doi: 10.1182/blood-2011-11-395269. Epub 2012 Jan 13.

38.

Intensive short-term chemotherapy regimen induces high remission rate (over 90%) and event-free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemia.

Todeschini G, Bonifacio M, Tecchio C, Balter R, Carli G, Stefani PM, Adami F, Zamò A, Dei Tos AP, Marino F, Gherlinzoni F, Marradi P, Semenzato G, Pizzolo G.

Am J Hematol. 2012 Jan;87(1):22-5. doi: 10.1002/ajh.22189. Epub 2011 Nov 16.

39.

Long-term persistence of molecular response after discontinuation of interferon-alpha in two patients with chronic myeloid leukaemia.

Veneri D, Tecchio C, De Matteis G, Paviati E, Benati M, Franchini M, Pizzolo G.

Blood Transfus. 2012 Apr;10(2):233-4. doi: 10.2450/2011.0057-11. Epub 2011 Sep 22. No abstract available.

40.

Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis.

Rossini M, Zanotti R, Bonadonna P, Artuso A, Caruso B, Schena D, Vecchiato D, Bonifacio M, Viapiana O, Gatti D, Senna G, Riccio A, Passalacqua G, Pizzolo G, Adami S.

Bone. 2011 Oct;49(4):880-5. doi: 10.1016/j.bone.2011.07.004. Epub 2011 Jul 14.

PMID:
21782049
41.

BRAF mutations in hairy-cell leukemia.

Tiacci E, Trifonov V, Schiavoni G, Holmes A, Kern W, Martelli MP, Pucciarini A, Bigerna B, Pacini R, Wells VA, Sportoletti P, Pettirossi V, Mannucci R, Elliott O, Liso A, Ambrosetti A, Pulsoni A, Forconi F, Trentin L, Semenzato G, Inghirami G, Capponi M, Di Raimondo F, Patti C, Arcaini L, Musto P, Pileri S, Haferlach C, Schnittger S, Pizzolo G, Foà R, Farinelli L, Haferlach T, Pasqualucci L, Rabadan R, Falini B.

N Engl J Med. 2011 Jun 16;364(24):2305-15. doi: 10.1056/NEJMoa1014209. Epub 2011 Jun 11.

42.

Primary role of multiparametric flow cytometry in the diagnostic work-up of indolent clonal mast cell disorders.

Perbellini O, Zamò A, Colarossi S, Zampieri F, Zoppi F, Bonadonna P, Schena D, Artuso A, Martinelli G, Chilosi M, Pizzolo G, Zanotti R.

Cytometry B Clin Cytom. 2011 Nov;80(6):362-8. doi: 10.1002/cyto.b.20606. Epub 2011 Jun 8.

43.

Notch-3 and Notch-4 signaling rescue from apoptosis human B-ALL cells in contact with human bone marrow-derived mesenchymal stromal cells.

Nwabo Kamdje AH, Mosna F, Bifari F, Lisi V, Bassi G, Malpeli G, Ricciardi M, Perbellini O, Scupoli MT, Pizzolo G, Krampera M.

Blood. 2011 Jul 14;118(2):380-9. doi: 10.1182/blood-2010-12-326694. Epub 2011 May 20.

44.

A proliferation-inducing ligand (APRIL) serum levels predict time to first treatment in patients affected by B-cell chronic lymphocytic leukemia.

Tecchio C, Nichele I, Mosna F, Zampieri F, Leso A, Al-Khaffaf A, Veneri D, Andreini A, Pizzolo G, Ambrosetti A.

Eur J Haematol. 2011 Sep;87(3):228-34. doi: 10.1111/j.1600-0609.2011.01650.x. Epub 2011 Jul 26.

PMID:
21595749
45.

Toll-like receptor-3-activated human mesenchymal stromal cells significantly prolong the survival and function of neutrophils.

Cassatella MA, Mosna F, Micheletti A, Lisi V, Tamassia N, Cont C, Calzetti F, Pelletier M, Pizzolo G, Krampera M.

Stem Cells. 2011 Jun;29(6):1001-11. doi: 10.1002/stem.651.

46.

Pro-apoptotic activity of α-bisabolol in preclinical models of primary human acute leukemia cells.

Cavalieri E, Rigo A, Bonifacio M, Carcereri de Prati A, Guardalben E, Bergamini C, Fato R, Pizzolo G, Suzuki H, Vinante F.

J Transl Med. 2011 Apr 21;9:45. doi: 10.1186/1479-5876-9-45.

47.

AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance.

Avvisati G, Lo-Coco F, Paoloni FP, Petti MC, Diverio D, Vignetti M, Latagliata R, Specchia G, Baccarani M, Di Bona E, Fioritoni G, Marmont F, Rambaldi A, Di Raimondo F, Kropp MG, Pizzolo G, Pogliani EM, Rossi G, Cantore N, Nobile F, Gabbas A, Ferrara F, Fazi P, Amadori S, Mandelli F; GIMEMA, AIEOP, and EORTC Cooperative Groups.

Blood. 2011 May 5;117(18):4716-25. doi: 10.1182/blood-2010-08-302950. Epub 2011 Mar 8.

48.

Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases.

Raponi S, De Propris MS, Intoppa S, Milani ML, Vitale A, Elia L, Perbellini O, Pizzolo G, Foá R, Guarini A.

Leuk Lymphoma. 2011 Jun;52(6):1098-107. doi: 10.3109/10428194.2011.559668. Epub 2011 Feb 24.

PMID:
21348573
49.

Idiopathic thrombocytopenia and Helicobacter pylori infection: platelet count increase and early eradication therapy.

Veneri D, Bonani A, Franchini M, Fedrizzi A, Pizzolo G.

Blood Transfus. 2011 Jul;9(3):340-2. doi: 10.2450/2011.0014-10. Epub 2011 Jan 13. No abstract available.

50.

Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis.

Zanotti R, Bonadonna P, Bonifacio M, Artuso A, Schena D, Rossini M, Perbellini O, Colarossi S, Chilosi M, Pizzolo G.

Haematologica. 2011 Mar;96(3):482-4. doi: 10.3324/haematol.2010.034553. Epub 2010 Dec 29. No abstract available.

Supplemental Content

Loading ...
Support Center